AstraZeneca Settles Seroquel Suits For A Third Of What Lilly Paid For Zyprexa
Executive Summary
In deciding to settle rather than continue to litigate Seroquel (quetiapine) product liability claims, AstraZeneca is following the path Lilly took in resolving suits over its antipsychotic Zyprexa (olanzapine). But the financial burden won't be as heavy for AstraZeneca
You may also be interested in...
AstraZeneca Faces Government Probe Of Synagis Sales And Marketing
The investigation comes one year after the company reached a settlement with the DoJ over its Seroquel marketing and as it faces probe over its relationship with Medco.
AstraZeneca Faces Government Probe Of Synagis Sales And Marketing
The investigation comes one year after the company reached a settlement with the DoJ over its Seroquel marketing and as it faces probe over its relationship with Medco.
Seroquel XR Remission Claims Challenged By FDA As AstraZeneca Puts Lawsuits To Rest
"Remission" has no regulatory definition in major depressive disorder, FDA says in letter citing a sales rep aid left with doctors.